Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2008-03-18
2008-03-18
Parkin, Jeffrey S. (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388730
Reexamination Certificate
active
11544346
ABSTRACT:
This invention provides an antibody capable of specifically inhibiting the fusion of an HIV-1 envelope glycoprotein+cell with an appropriate CD4+cell without cross reacting with the HIV-1 envelope glycoprotein or CD4 and capable of inhibiting infection by one or more strains of HIV-1. This antibody is then used to identify a molecule which is important for HIV infection. Different uses of the antibody and the molecule are described.
REFERENCES:
patent: 4886743 (1989-12-01), Hood
patent: 5021409 (1991-06-01), Murrer et al.
patent: 5071964 (1991-12-01), Dustin et al.
patent: 5091513 (1992-02-01), Huston et al.
patent: 5126433 (1992-06-01), Maddon et al.
patent: 5215913 (1993-06-01), Posner
patent: 5225539 (1993-07-01), Winter et al.
patent: 5440021 (1995-08-01), Chuntharapai et al.
patent: 5449608 (1995-09-01), Young et al.
patent: 5504003 (1996-04-01), Li et al.
patent: 5603933 (1997-02-01), Dwyer et al.
patent: 5668149 (1997-09-01), Oroszlan et al.
patent: 5817767 (1998-10-01), Allaway
patent: 5854400 (1998-12-01), Chang et al.
patent: 5939320 (1999-08-01), Littman et al.
patent: 5994515 (1999-11-01), Hoxie et al.
patent: 6025154 (2000-02-01), Li et al.
patent: 6100087 (2000-08-01), Rossi et al.
patent: 6107019 (2000-08-01), Allaway et al.
patent: 6258527 (2001-07-01), Littman et al.
patent: 6258782 (2001-07-01), Barney et al.
patent: 6261763 (2001-07-01), Allaway et al.
patent: 6265184 (2001-07-01), Gray et al.
patent: 6268477 (2001-07-01), Gray et al.
patent: 6344545 (2002-02-01), Allaway et al.
patent: 6448375 (2002-09-01), Samson
patent: 6511826 (2003-01-01), Li et al.
patent: 7175988 (2003-02-01), Roschke et al.
patent: 6528625 (2003-03-01), Wu et al.
patent: 6548636 (2003-04-01), Dragic
patent: 6692938 (2004-02-01), Samson et al.
patent: 6743594 (2004-06-01), Li
patent: 6759519 (2004-07-01), Li et al.
patent: 6797811 (2004-09-01), Gray et al.
patent: 6800447 (2004-10-01), Samson
patent: 6800729 (2004-10-01), Li et al.
patent: 6908734 (2005-06-01), Dragic et al.
patent: 6930174 (2005-08-01), Samson et al.
patent: 6972126 (2005-12-01), Allaway et al.
patent: 7060273 (2006-06-01), Olson et al.
patent: 7118859 (2006-10-01), Litwin et al.
patent: 7122185 (2006-10-01), Olson et al.
patent: 7129055 (2006-10-01), Littman et al.
patent: 7138119 (2006-11-01), Olson et al.
patent: 2001/0000241 (2001-04-01), Li et al.
patent: 2001/0046512 (2001-11-01), Litwin et al.
patent: 2002/0045161 (2002-04-01), Allaway et al.
patent: 2002/0048786 (2002-04-01), Rosen et al.
patent: 2002/0061834 (2002-05-01), Rosen et al.
patent: 2002/0068813 (2002-06-01), Dragic et al.
patent: 2002/0146415 (2002-10-01), Olson et al.
patent: 2002/0150888 (2002-10-01), Gray et al.
patent: 2002/0155429 (2002-10-01), Allaway et al.
patent: 2003/0003440 (2003-01-01), Lopalco et al.
patent: 2003/0023044 (2003-01-01), Li et al.
patent: 2003/0092632 (2003-05-01), Dragic et al.
patent: 2003/0166024 (2003-09-01), Rosen et al.
patent: 2003/0166870 (2003-09-01), Wu et al.
patent: 2003/0195348 (2003-10-01), Combadiere et al.
patent: 2004/0062767 (2004-04-01), Olson et al.
patent: 2004/0086528 (2004-05-01), Allaway et al.
patent: 2004/0110127 (2004-06-01), Samson et al.
patent: 2004/0151719 (2004-08-01), Li et al.
patent: 2004/0161739 (2004-08-01), Samson et al.
patent: 2004/0228869 (2004-11-01), Olson et al.
patent: 2004/0230037 (2004-11-01), Gray et al.
patent: 2004/0259785 (2004-12-01), Combadiere et al.
patent: 2005/0118677 (2005-06-01), Combadiere et al.
patent: 2005/0154193 (2005-07-01), Roschke et al.
patent: 2005/0260565 (2005-11-01), Gray et al.
patent: 2006/0029932 (2006-02-01), Allaway et al.
patent: 2006/0140977 (2006-06-01), Allaway et al.
patent: 2006/0194244 (2006-08-01), Allaway et al.
patent: 2006/0233798 (2006-10-01), Olson et al.
patent: 2007/0026441 (2007-02-01), Olson et al.
patent: 2216990 (1997-12-01), None
patent: 96870021.1 (1996-03-01), None
patent: 96870102.9 (1996-08-01), None
patent: 0815137 (1996-12-01), None
patent: 1145721 (2001-10-01), None
patent: 1146055 (2001-10-01), None
patent: 1146122 (2001-10-01), None
patent: 1148126 (2001-10-01), None
patent: 1148127 (2001-10-01), None
patent: 1149582 (2001-10-01), None
patent: 1199360 (2002-04-01), None
patent: 0883687 (2004-10-01), None
patent: 1482042 (2004-12-01), None
patent: WO92/01451 (1992-02-01), None
patent: WO94/22477 (1994-10-01), None
patent: WO95/16789 (1995-06-01), None
patent: WO96/39437 (1996-12-01), None
patent: WO96/41020 (1996-12-01), None
patent: WO97/22698 (1997-06-01), None
patent: WO97/26009 (1997-07-01), None
patent: WO97/28258 (1997-08-01), None
patent: WO97/032019 (1997-09-01), None
patent: WO97/37005 (1997-10-01), None
patent: WO97/44055 (1997-11-01), None
patent: WO 97/44462 (1997-11-01), None
patent: WO97/45543 (1997-12-01), None
patent: WO97/47318 (1997-12-01), None
patent: WO97/47319 (1997-12-01), None
patent: WO97/49424 (1997-12-01), None
patent: WO98/18826 (1998-05-01), None
patent: WO 98/56421 (1998-12-01), None
patent: WO 00/35409 (2000-06-01), None
patent: WO 01/55439 (2001-08-01), None
patent: WO 01/58915 (2001-08-01), None
patent: WO 01/58916 (2001-08-01), None
patent: WO 01/64710 (2001-09-01), None
patent: WO 02/22077 (2002-03-01), None
patent: WO 02/064612 (2002-08-01), None
patent: WO 02/068608 (2002-09-01), None
patent: WO 02/083172 (2002-10-01), None
patent: WO 03/072766 (2003-09-01), None
patent: WO 07/014114 (2007-02-01), None
Abaza, M.S.I et al., (1992) “Effects of Amino Acid Substitutions Outside An Antigenic Site On Protein Binding To Monoclonal Antibodies Of Predetermined Specificity Obtained By Peptide Immunization: Demonstration With Region 94-100 (Antigenic Site 3) Of Myoglobin”,J. Prot. Chem. 11:433-443.
Alexander, H. et al., (1992) “Altering The Antigenicity Of Proteins”,Proc. Natl. Acad. Sci. 89:3352-3356.
Ashorn, P.A. et al., (1990) “Human Immunodeficiency Virus Envelope Glycoprotein/CD4 Mediated Fusion Of Nonprimate Cells With Human Cells”,J. Virol. 64:2149-2156.
Attanasio, R. et al., (1991) “Anti-Idiotypic Antibody Response To Monoclonal Anti-CD4 Preparations In Nonhuman Primate Species”,J. Immunol. 146:507-514.
Brenner, T.J. et al., (1996) “Relation Between HIV-1 Syncytium Inhibition Antibodies And Clinical Outcome In Children”,Lancet337:1001-1005.
Broder, C.C. et al., (1993) “The Block To HIV-1 Envelope Glycoprotein-Mediated Membrane Fusion In Animal Cells Expressing Human CD4 Can Be Overcome By A Human Cell Component (s)”, Virol. 193:483-491.
Busso, M. et al., (1991) “HIV-Induced Syncytium Formation Requires The Formation Of Conjugates Between Virus-Infected And Uninfected T-Cells In Vitro”,AIDS5:1425-1432.
Clapham, P.R. et al., (1991) “Specific Cell Surface Requirements For The Infection Of CD4-Positive Cells By Human Immunodeficiency Virus Types 1 And 2 By Simian Immunodeficiency Virus”,Virol. 181:703-715.
Dalgleish, A.G., (1995) “HIV And CD26”,Nat. Med. 1:881-882.
Dragic, T. et al., (1992) “Complementation Of Murine Cells For Human Immunodeficiency Virus Envelope/CD4-Mediated Fusion In Human/ Murine Heterokaryons”,J. Virol. 66:4794-4802.
Dragic, T.V. et al., (1995) “Proteinase-Resistant Factors In Human Erythrocyte Membranes Mediate CD-4 Dependent Fusion With Cells Expressing Human Immunodeficiency Virus Type 1 Envelope Glycoproteins”,J. Virol. 69:1013-1018.
Golding, H. et al., (1992) “LFA-1 Adhesion Molecules Are Not Involved In The Early Stages Of HIV-1env-Mediated Cell Membrane Fusion”,AIDS Res. Hum. Retroviruses8:1593-1598.
Harrington, R.D. And Geballe, A.P., (1993) “Cofactor Requirement For Human Immunodeficiency Virus Type 1 Entry Into A CD4-Expressing Human Cell Line”,J. Virol. 67:5939-5947.
Hattori, T. et al., (1989) “Involvement Of Tryptase-Related Cellular Protease(s) In Human Immunodeficiency Virus Type 1 Infection”,FEBS Letters248:48-52.
Hildreth, J.E. et al., (1989) “Involvement Of A Leukocyte Adhesion Receptor (LFA-1) In HIV-Induced Syncytium Formation”Science244:10
Allaway Graham P.
Litwin Virginia M.
Maddon Paul J.
Cooper & Dunham LLP
Parkin Jeffrey S.
Progenics Pharmaceuticals Inc.
White John P.
LandOfFree
Compounds capable of inhibiting HIV-1 infection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds capable of inhibiting HIV-1 infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds capable of inhibiting HIV-1 infection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3920413